Literature DB >> 6786600

Relation of angiographically defined coronary artery disease to plasma lipoprotein subfractions and apolipoproteins.

N E Miller, F Hammett, S Saltissi, S Rao, H van Zeller, J Coltart, B Lewis.   

Abstract

The relation of coronary artery disease to plasma lipoproteins was examined in 104 men aged 35-65 years undergoing coronary angiography for suspected myocardial ischaemia. A score reflecting the number, degree, and length of stenoses in seven major coronary arteries was assigned to each angiogram. Lipid concentrations in lipoprotein subfractions were measured after preparative ultracentrifugation; plasma apolipoprotein concentrations were measured by electroimmunoassay. Men with high coronary scores tended to have lower plasma high-density lipoprotein (HDL) cholesterol concentrations and higher low-density lipoprotein (density 1.019-1.063 g/ml) cholesterol concentrations than subjects of similar age with low coronary scores (p approximately equal to 0.1). The strongest relation, however, was with the cholesterol concentration in the HDL2 subfraction (density 1.063-1.125 g/ml) of HDL, which averaged 44% lower in the severely affected patients (p less than 0.005). No associations were found between the coronary score and HDL3 cholesterol, the cholesterol content of lipoproteins of density less than 1.019 g/ml, plasma triglyceride, or the concentrations of apolipoproteins AI, AII, and E. The high coronary scores associated with low HDL2 concentrations reflected an increase in the number of both partial and complete stenoses distributed throughout the coronary tree. In contrast the sizes of the lesions and the proportion producing complete occlusion were unrelated to HDL2.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6786600      PMCID: PMC1505739          DOI: 10.1136/bmj.282.6278.1741

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN: 0267-0623


  20 in total

1.  The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum.

Authors:  R J HAVEL; H A EDER; J H BRAGDON
Journal:  J Clin Invest       Date:  1955-09       Impact factor: 14.808

Review 2.  Human serum lipoproteins and their interrelationships.

Authors:  A V Nichols
Journal:  Adv Biol Med Phys       Date:  1967

Review 3.  Fat transport in lipoproteins--an integrated approach to mechanisms and disorders.

Authors:  D S Fredrickson; R I Levy; R S Lees
Journal:  N Engl J Med       Date:  1967-01-05       Impact factor: 91.245

4.  Subfractionation of human high density lipoproteins by heparin-Sepharose affinity chromatography.

Authors:  K H Weisgraber; R W Mahley
Journal:  J Lipid Res       Date:  1980-03       Impact factor: 5.922

5.  Ischemic heart disease, atherosclerosis, and longevity.

Authors:  J W Gofman; W Young; R Tandy
Journal:  Circulation       Date:  1966-10       Impact factor: 29.690

6.  HDL cholesterol and other lipids in coronary heart disease. The cooperative lipoprotein phenotyping study.

Authors:  W P Castelli; J T Doyle; T Gordon; C G Hames; M C Hjortland; S B Hulley; A Kagan; W J Zukel
Journal:  Circulation       Date:  1977-05       Impact factor: 29.690

7.  High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study.

Authors:  T Gordon; W P Castelli; M C Hjortland; W B Kannel; T R Dawber
Journal:  Am J Med       Date:  1977-05       Impact factor: 4.965

8.  Serum high density lipoprotein cholesterol in patients with abnormal coronary arteries.

Authors:  M H Tan; W Macintosh; K L Weldon; A Kapoor; B M Chandler; T J Hindmarsh
Journal:  Atherosclerosis       Date:  1980-10       Impact factor: 5.162

9.  Quantitative studies of very low density lipoprotein: conversion to low density lipoprotein in normal controls and primary hyperlipidaemic states and the role of direct secretion of low density lipoprotein in heterozygous familial hypercholesterolaemia.

Authors:  E D Janus; A Nicoll; R Wootton; P R Turner; P J Magill; B Lewis
Journal:  Eur J Clin Invest       Date:  1980-04       Impact factor: 4.686

10.  The Tromsø heart-study. High-density lipoprotein and coronary heart-disease: a prospective case-control study.

Authors:  N E Miller; D S Thelle; O H Forde; O D Mjos
Journal:  Lancet       Date:  1977-05-07       Impact factor: 79.321

View more
  42 in total

Review 1.  IDL, VLDL, chylomicrons and atherosclerosis.

Authors:  B G Nordestgaard; A Tybjaerg-Hansen
Journal:  Eur J Epidemiol       Date:  1992-05       Impact factor: 8.082

2.  Opportunities for using lipoprotein subclass profile by nuclear magnetic resonance spectroscopy in assessing insulin resistance and diabetes prediction.

Authors:  Alexis C Frazier-Wood; W Timothy Garvey; Tara Dall; Robert Honigberg; Ray Pourfarzib
Journal:  Metab Syndr Relat Disord       Date:  2012-04-25       Impact factor: 1.894

3.  High-density lipoprotein subfractions in normolipidemic individuals without clinical atherosclerosis lipoprotein subfractions in an adult population.

Authors:  Fabio L Sodré; Vera S Castanho; Lucia N Castilho; Silvia de Barros-Mazon; Eliana C de Faria
Journal:  J Clin Lab Anal       Date:  2006       Impact factor: 2.352

4.  Serum apolipoproteins AI and B and lipoproteins in middle aged men with and without previous myocardial infarction.

Authors:  P N Durrington; L Hunt; M Ishola; J Kane; W P Stephens
Journal:  Br Heart J       Date:  1986-09

5.  Impaired intravascular lipolysis with changes in concentrations of high density lipoprotein subclasses in young smokers.

Authors:  W Richmond; P W Seviour; T K Teal; R S Elkeles
Journal:  Br Med J (Clin Res Ed)       Date:  1987-07-25

6.  Effects of prazosin and alphamethyldopa on blood lipids and lipoproteins in hypertensive patients.

Authors:  M Velasco; H Silva; E Feldstein; R Pellicer; J Morillo; A Urbina-Quintana; O Hernández-Pieretti
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

7.  Should studies of patients undergoing coronary angiography be used to evaluate the role of behavioral risk factors for coronary heart disease?

Authors:  T G Pickering
Journal:  J Behav Med       Date:  1985-09

8.  Medical conditions underlying recurrence of retinal vein occlusion.

Authors:  P M Dodson; A J Kubicki; K G Taylor; E E Kritzinger
Journal:  Br J Ophthalmol       Date:  1985-07       Impact factor: 4.638

Review 9.  Gene activation regresses atherosclerosis, promotes health, and enhances longevity.

Authors:  Pauli V Luoma
Journal:  Lipids Health Dis       Date:  2010-07-06       Impact factor: 3.876

10.  Retinal vein occlusion and the prevalence of lipoprotein abnormalities.

Authors:  P M Dodson; D J Galton; A M Hamilton; R K Blach
Journal:  Br J Ophthalmol       Date:  1982-03       Impact factor: 4.638

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.